Short answer · Medically reviewed summary · Last updated: 2026-04-07
Epilepsy is a common neurological disorder affecting approximately 50 million people worldwide, with an estimated prevalence of 4 to 10 cases per 1,000 individuals in the general population. While often considered a chronic condition, the incidence varies significantly by age, with the highest rates of new diagnoses occurring in young children and older adults. What is the global prevalence and incidence of Epilepsy? According to the World Health Organization (WHO), Epilepsy is one of the most common neurological diseases globally.
1 people with Epilepsy have shared their first-person experience on this question at DiseaseMaps.
Epilepsy is a common neurological disorder affecting approximately 50 million people worldwide, with an estimated prevalence of 4 to 10 cases per 1,000 individuals in the general population. While often considered a chronic condition, the incidence varies significantly by age, with the highest rates of new diagnoses occurring in young children and older adults.
According to the World Health Organization (WHO), Epilepsy is one of the most common neurological diseases globally. Prevalence rates suggest that nearly 50 million people are currently living with the condition. The annual incidence—the number of new cases diagnosed each year—is estimated at approximately 40 to 70 per 100,000 people in developed countries, though this number can be significantly higher in low- and middle-income countries, often ranging from 100 to 190 per 100,000. It is important to note that these figures are estimates; the true prevalence of Epilepsy is likely higher due to underreporting, social stigma, and misdiagnosis in regions with limited access to neurological care.
Epilepsy can manifest at any stage of life, but the distribution of onset is bimodal. We observe the highest incidence rates in early childhood and again in individuals over the age of 65. In children, genetic factors and developmental anomalies are frequent contributors, whereas in older adults, Epilepsy is often secondary to strokes, tumors, or neurodegenerative processes. Regarding gender distribution, clinical studies generally show a slightly higher incidence in males than in females, though the difference is often marginal and can vary based on the underlying etiology of the seizures.
Accurately mapping the prevalence of Epilepsy remains a significant challenge for epidemiologists. Several factors contribute to the difficulty in obtaining precise global numbers:
Geographic disparities in Epilepsy prevalence are largely driven by socioeconomic factors rather than ethnicity. In regions where infectious diseases (such as neurocysticercosis or malaria), birth trauma, and poor access to prenatal care are more prevalent, the incidence of the condition is notably higher. Consequently, the burden of Epilepsy is disproportionately concentrated in low- and middle-income nations, where the lack of long-term management resources can lead to higher rates of uncontrolled seizures.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.